EATG » Access

Access

Beware the Global Fund procurement cliff

Safeguarding supply of affordable quality medicines and diagnostics in context of risky transitions and co-financing For the last two decades, the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global…

Deportation fears, uncertainty over health insurance and stigma are barriers to accessing HIV services for undocumented African migrants in the US

Qualitative research carried out with undocumented African migrants in New York City revealed that fears of discovery and deportation presented a substantial barrier to seeking out HIV testing services and…

New essential medicines and diagnostics lists published

WHO updates global guidance on medicines and diagnostic tests to address health challenges, prioritize highly effective therapeutics, and improve affordable access 9 July 2019, Geneva: WHO’s Essential Medicines List and…

HHS gets a new HIV prevention patent, but will the agency demand royalties from Gilead?

For the past several months, the U.S. government has been lambasted by AIDS activists for ostensibly failing to seek royalties from Gilead Sciences (GILD) for an expensive HIV prevention pill sold by…

MSF: Gilead Sciences fails on promise to expand access to lifesaving drug for people living with HIV

Inaction by US pharmaceutical corporation Gilead to follow through on its so-called ‘access initiative’ leaves people unable to access a vital drug to treat a deadly infection. Read the full…

Nine HIV diagnoses in men on PrEP waiting list, Manchester

Nine gay men are known to have seroconverted since being put on a waiting list for pre-exposure prophylaxis (PrEP) at a single Manchester clinic, Dr Sally Jewsbury told the British…

As global markets for generic drugs fail, poor people pay the price

Healthy competition from generic drugs is often held up as a “cure” for high drug prices — a shared concern across rich and developing countries alike. For many low- and…

Medicines shortages: take part in a survey of the EU Civil Society Forum on HIV, Hepatitis and TB

A month ago more than 30 Civil Society organisations reached out to the European Commission asking for a strong EU engagement to tackle the issue of medicines shortages. Now, the EU…

New resource gateway launched on innovation & access to medicines

A new Knowledge Portal that aims to ease policymakers’ access to reliable information about themes in medicines access, pricing and pharma innovation was launched today by the Global Health Centre of Geneva’s…

UK, Germany, dissociate from WHO drug pricing resolution

The passage of a landmark resolution on improving the transparency of markets for medicines at the latest WHA fails to narrow the political divide. John Zarocostas reports from Geneva. Few…

1 2 3 47